Maria Grazia Roncarolo
Director/Board Member bei COSMO PHARMACEUTICALS N.V.
Vermögen: 166 950 $ am 30.04.2024
Aktive Positionen von Maria Grazia Roncarolo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| COSMO PHARMACEUTICALS N.V. | Director/Board Member | 01.04.2012 | - |
| Independent Dir/Board Member | 01.04.2012 | - | |
| ATARA BIOTHERAPEUTICS, INC. | Director/Board Member | 11.05.2020 | - |
| Independent Dir/Board Member | 11.05.2020 | - | |
Ospedale San Raffaele Srl
 Ospedale San Raffaele Srl Hospital/Nursing ManagementHealth Services Ospedale San Raffaele Srl is engaged in hospital business. The company is headquartered in Milan, Italy. | Corporate Officer/Principal | 01.07.2003 | - |
| Academia Europaea Ltd | Corporate Officer/Principal | 01.01.2005 | - |
| Institute For Stem Cell Biology & Regenerative Medicine | Corporate Officer/Principal | 01.06.2014 | - |
| Stanford University | Corporate Officer/Principal | 01.03.2014 | - |
| Federation of Clinical Immunology Societies | President | 01.01.2018 | - |
Karriereverlauf von Maria Grazia Roncarolo
Ehemalige bekannte Positionen von Maria Grazia Roncarolo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| San Raffaele School of Medicine | Corporate Officer/Principal | 01.03.2007 | 01.06.2014 |
Fondazione San Raffaele del Monte Tabor-Milano
 Fondazione San Raffaele del Monte Tabor-Milano Hospital/Nursing ManagementHealth Services Fondazione San Raffaele del Monte Tabor-Milano provides medical care and clinical support to patients. They carry out biomedical research and clinical activities. The company is based in Milan, Italy. | Chief Tech/Sci/R&D Officer | 01.01.2008 | 01.01.2013 |
| ░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Maria Grazia Roncarolo
| University of Turin | Doctorate Degree |
Statistik
International
| Italien | 7 |
| Vereinigte Staaten | 6 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 5 |
| Director/Board Member | 4 |
| Independent Dir/Board Member | 3 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Health Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| COSMO PHARMACEUTICALS N.V. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Cosmo Pharmaceuticals SA
 Cosmo Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cosmo Pharmaceuticals SA operates as a pharmaceutical company that engages in the manufacturing of pharmaceutical drugs. It focuses on the development of gastro-intestinal pharmaceutical products for the treatment of inflammatory bowel diseases, colon infections and colon diagnosis, and treated skin disorders. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Lainate, Italy. | Health Technology |
Ospedale San Raffaele Srl
Ospedale San Raffaele Srl Hospital/Nursing ManagementHealth Services Ospedale San Raffaele Srl is engaged in hospital business. The company is headquartered in Milan, Italy. | Health Services |
Fondazione San Raffaele del Monte Tabor-Milano
Fondazione San Raffaele del Monte Tabor-Milano Hospital/Nursing ManagementHealth Services Fondazione San Raffaele del Monte Tabor-Milano provides medical care and clinical support to patients. They carry out biomedical research and clinical activities. The company is based in Milan, Italy. | Health Services |
| Academia Europaea Ltd | |
| Federation of Clinical Immunology Societies | |
| Institute For Stem Cell Biology & Regenerative Medicine | |
| San Raffaele-Telethon Institute for Gene Therapy | |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Maria Grazia Roncarolo
- Erfahrung
